Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Overview

This study presents a novel method for quantifying metastatic tumor burden in ovarian cancer using red fluorescent protein (RFP)-labeled tumor cells. The technique enhances imaging accuracy by eliminating tissue autofluorescence, allowing for precise measurement of tumor burden in a murine model.

Key Study Components

Area of Science

• Ovarian cancer research
• Metastasis quantification
• Optical imaging techniques

Background

• Ovarian cancer often presents with diffuse intra-peritoneal lesions.
• Accurate quantitation of tumor burden is crucial for therapeutic monitoring.
• Existing imaging methods may be hindered by tissue autofluorescence.
• RFP-labeled cells provide a solution for clearer imaging.

Purpose of Study

• To develop a reliable imaging method for assessing tumor burden.
• To facilitate understanding of ovarian cancer metastasis regulation.
• To improve monitoring of therapeutic efficacy in ovarian cancer.

Methods Used

• Use of RFP-labeled tumor cells in a syngeneic orthotopic xenograft model.
• Optical imaging to visualize and quantify tumor burden.
• Un-mixing of fluorescent spectra to reduce autofluorescence interference.
• Analytical procedures to extract quantitative data from images.

Main Results

• Successful visualization of tumor burden in murine models.
• Quantitative data supports the efficacy of the imaging technique.
• Insights gained into the dynamics of ovarian cancer metastasis.
• Potential applications in therapeutic monitoring.

Conclusions

• The method provides a robust approach to quantifying tumor burden.
• It enhances the understanding of ovarian cancer metastasis.
• The technique may improve therapeutic assessment in clinical settings.

Frequently Asked Questions